Correction
Published on 13 Jun 2025
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
in Multiple Sclerosis and Neuroimmunology
- 300 views
Correction
Published on 13 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 10 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 06 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Accepted on 05 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Accepted on 04 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 04 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 03 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 03 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 02 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 02 Jun 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 29 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 28 May 2025
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Accepted on 27 May 2025
in Multiple Sclerosis and Neuroimmunology
Mini Review
Accepted on 26 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 22 May 2025
in Multiple Sclerosis and Neuroimmunology
Review
Published on 21 May 2025
in Multiple Sclerosis and Neuroimmunology